ABUS
Price
$3.32
Change
-$0.02 (-0.60%)
Updated
Jan 24 closing price
Capitalization
629.11M
32 days until earnings call
VCYT
Price
$43.81
Change
-$0.26 (-0.59%)
Updated
Jan 24 closing price
Capitalization
1.66B
36 days until earnings call
Ad is loading...

ABUS vs VCYT

Header iconABUS vs VCYT Comparison
Open Charts ABUS vs VCYTBanner chart's image
Arbutus Biopharma
Price$3.32
Change-$0.02 (-0.60%)
Volume$412.24K
Capitalization629.11M
Veracyte
Price$43.81
Change-$0.26 (-0.59%)
Volume$652.53K
Capitalization1.66B
ABUS vs VCYT Comparison Chart
Loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABUS vs. VCYT commentary
Jan 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a Buy and VCYT is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 26, 2025
Stock price -- (ABUS: $3.32 vs. VCYT: $43.81)
Brand notoriety: ABUS and VCYT are both not notable
ABUS represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABUS: 50% vs. VCYT: 86%
Market capitalization -- ABUS: $629.11M vs. VCYT: $1.66B
ABUS [@Biotechnology] is valued at $629.11M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.77B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • ABUS’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than ABUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • ABUS’s TA Score: 4 bullish, 3 bearish.
  • VCYT’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than ABUS.

Price Growth

ABUS (@Biotechnology) experienced а +3.75% price change this week, while VCYT (@Medical Specialties) price change was +7.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.98%. For the same industry, the average monthly price growth was +3.55%, and the average quarterly price growth was -0.92%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.63%. For the same industry, the average monthly price growth was +5.20%, and the average quarterly price growth was +2.19%.

Reported Earning Dates

ABUS is expected to report earnings on May 01, 2025.

VCYT is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+3.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+2.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than ABUS($629M). VCYT YTD gains are higher at: 10.631 vs. ABUS (1.529). VCYT has higher annual earnings (EBITDA): -49.41M vs. ABUS (-75.14M). VCYT has more cash in the bank: 216M vs. ABUS (128M). ABUS has less debt than VCYT: ABUS (1.45M) vs VCYT (12.6M). VCYT has higher revenues than ABUS: VCYT (361M) vs ABUS (6.74M).
ABUSVCYTABUS / VCYT
Capitalization629M1.66B38%
EBITDA-75.14M-49.41M152%
Gain YTD1.52910.63114%
P/E RatioN/AN/A-
Revenue6.74M361M2%
Total Cash128M216M59%
Total Debt1.45M12.6M11%
FUNDAMENTALS RATINGS
ABUS vs VCYT: Fundamental Ratings
ABUS
VCYT
OUTLOOK RATING
1..100
2567
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
8272
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
5537
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (38) in the Biotechnology industry is in the same range as ABUS (64). This means that VCYT’s stock grew similarly to ABUS’s over the last 12 months.

VCYT's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as ABUS (82). This means that VCYT’s stock grew similarly to ABUS’s over the last 12 months.

VCYT's SMR Rating (90) in the Biotechnology industry is in the same range as ABUS (98). This means that VCYT’s stock grew similarly to ABUS’s over the last 12 months.

VCYT's Price Growth Rating (37) in the Biotechnology industry is in the same range as ABUS (55). This means that VCYT’s stock grew similarly to ABUS’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ABUS (100). This means that VCYT’s stock grew similarly to ABUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABUSVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 20 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 26 days ago
83%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Ad is loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGSCX26.92-0.07
-0.26%
Federated Hermes MDT Mid Cap Growth C
HVEIX26.50-0.07
-0.26%
HVIA Equity Institutional
MLPNX7.04-0.02
-0.28%
Invesco SteelPath MLP Alpha Plus Y
PSICX44.11-0.13
-0.29%
PGIM Quant Solutions Large-Cap Index C
JGTUX42.41-0.18
-0.42%
JPMorgan Growth Advantage R4